Boule Diagnostics AB (publ) (STO:BOUL)
Sweden
· Delayed Price · Currency is SEK 9.04
+0.26 (2.96%)
Mar 28, 2025, 5:29 PM CET
Boule Diagnostics AB Revenue
In the year 2024, Boule Diagnostics AB had annual revenue of 558.50M SEK, down -2.25%. Boule Diagnostics AB had revenue of 143.20M in the quarter ending December 31, 2024, a decrease of -3.33%.
Revenue
558.50M
Revenue Growth
-2.25%
P/S Ratio
0.63
Revenue / Employee
2.79M
Employees
200
Market Cap
351.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 558.50M | -12.83M | -2.25% |
| Dec 31, 2023 | 571.33M | 23.24M | 4.24% |
| Dec 31, 2022 | 548.09M | 84.74M | 18.29% |
| Dec 31, 2021 | 463.34M | 62.89M | 15.70% |
| Dec 31, 2020 | 400.46M | -98.46M | -19.73% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.03B |
| Getinge AB | 34.76B |
| Sectra AB | 3.30B |
| Camurus AB | 1.87B |
| Medicover AB | 23.97B |
| Vitrolife AB | 3.61B |
| Vimian Group AB | 4.29B |
| Elekta AB | 17.88B |
Boule Diagnostics AB News
- 6 weeks ago - Q4 2024 Boule Diagnostics AB Earnings Call Transcript - GuruFocus
- 5 months ago - Q3 2024 Boule Diagnostics AB Earnings Call Transcript - GuruFocus